3 days ago
7
Just two days after launching a copycat version Wegovy’s new weight-loss pill, Hims & Hers Health Inc. said it will stop selling the drug.
The announcement comes a day after the US Food and Drug Administration said it was cracking down on copycat weight-loss treatments, like those sold by Hims.
After having “constructive conversations with stakeholders,” Hims decided to stop offering the treatment, the company said in a post on X Saturday.
Hims on Thursday announced plans to sell a cheaper version of Novo Nordisk A/S’s new Wegovy weight-loss pill. The drugmaker, which is pinning its comeback on the new pill, called the move illegal and threatened to take action.
Analysts had hailed the new Wegovy pill as one of the most successful drug launches in recent years — a badly needed win for the company.
The next day, the FDA announced its investigation. The Department of Health and Human Services also said it referred Hims to the Department of Justice for possible violations of federal law.
Read M...
English (US) ·